About us
We are interested in understanding the logic by which interactions
that are mediated by intrinsically disordered proteins can regulate
complex cellular processes and how defects in interactions lead to
disease. In our research, we are also addressing questions related to
protein misfolding and aggregation. Protein aggregation and amyloid
formation have been linked to a variety of neurodegenerative disorders
such as Alzheimer’s disease, Parkinson’s disease or Creutzfeldt-Jakob
disease. We are developing new computational approaches to study
protein aggregation and predict the structure proteins adopt in
amyloid fibrils. Using high-throughput screening methods, we further
aim at understanding which protein-protein interactions are affected
in neurodegenerative disorders such as Huntington's or
Creutzfeldt-Jakob disease, and more specifically, which signaling
pathways most perturbed.
We welcome any questions, comments, and bug reports. Please send an
email to Joerg Gsponer (gsponer AT msl.ubc.ca). If you would like your data to be added to NeuroGem or to add by yourself, please address your inquiries to
Joerg Gsponer.
Citation
D. Na et al. (2012) “NeuroGeM, a knowledgebase of genetic
modifiers in neurodegenerative diseases”
BMC Medical Genomics 2013, 6:52 (
link)
Visit:
Our lab |
Michael Smith Laboratories |
University of British Columbia
People inside
Joerg Gsponer
Department of Biochemistry and Molecular Biology
Centre for High-throughput Biology
University of British Columbia
Canada
|
|
|
In collaboration with
|
|
David Rubinsztein
Department of Medical Genetics
University of Cambridge
Cambridge Institute for Medical Research
UK
|
|
|
Cahir J. O'Kane
Department of Genetics
University of Cambridge
UK
|
|
Support
Joerg Gsponer, David C. Rubinsztein and Cahir J. O’Kane were supported by the Centres of Excellence in Neurodegeneration Research (CoEN).
Joerg Gsponer was supported by the Canadian Institutes of Health Research (CIHR).
David C. Rubinsztein was supported by the Medical Research Council (MRC) and a Wellcome Trust Principal Fellowship.